The economics of hemodialysis catheter-related infection prophylaxis

Area of Science:

• Nephrology
• Infectious Diseases
• Health Economics

Background:

• Hemodialysis central venous catheters (CVCs) are linked to significant patient morbidity, mortality, and healthcare costs.
• CVC-related infections are a primary driver of these elevated costs, with estimates ranging from $17,000 to $32,000 per hospitalization.
• Effective and economically viable strategies for CVC infection prophylaxis are crucial for optimizing hemodialysis vascular access management.

Purpose of the Study:

• To review the clinical impact of common interventions for preventing hemodialysis CVC infections.
• To evaluate the economic efficiency of these prophylactic strategies.
• To identify optimal strategies balancing infection risk reduction with patient well-being and cost-effectiveness.

Main Methods:

• Systematic review of existing literature on CVC infection prophylaxis in hemodialysis.
• Analysis of clinical outcomes, including infection rates and patient morbidity.
• Economic evaluation of intervention costs versus savings from infection prevention.

Main Results:

• The review synthesizes data on various prophylactic measures, assessing their efficacy in reducing CVC-related infections.
• Economic analyses highlight the cost-effectiveness of specific interventions compared to standard care.
• Findings indicate that the value of prophylactic strategies depends on implementation costs and the resulting decrease in infection rates.

Conclusions:

• Implementing effective CVC infection prophylaxis is essential for improving patient safety and reducing healthcare expenditures in hemodialysis.
• The optimal strategy minimizes patient risk, inconvenience, and cost while maximizing infection prevention.
• Further research into cost-effective prophylactic interventions is warranted to enhance hemodialysis vascular access care.